Haibo Wang
Corporate Officer/Principal bij HARPOON THERAPEUTICS, INC.
Profiel
Haibo Wang is a professional who currently holds the position of Senior Vice President-Business Development at Harpoon Therapeutics, Inc. He previously worked as Vice President-Business Development at Hummingbird Bioscience Pte Ltd.
Wang holds an MBA from Duke University, a graduate degree from The Johns Hopkins University, and an undergraduate degree from Tsinghua University.
Actieve functies van Haibo Wang
| Bedrijven | Functie | Begin |
|---|---|---|
| HARPOON THERAPEUTICS, INC. | Corporate Officer/Principal | 01-08-2023 |
Eerdere bekende functies van Haibo Wang
| Bedrijven | Functie | Einde |
|---|---|---|
Hummingbird Bioscience Pte Ltd.
 Hummingbird Bioscience Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Hummingbird Bioscience Pte Ltd. operates as a biotechnology company. It engages in the research and development of novel cancer immuno-therapeutics. The firm develops antibodies against a number of oncology and immuno-oncology targets. The company was founded by Jerome Boyd-Kirkup, Piers Ingram, and Lan Zhang in 2015 and is headquartered in Singapore. | Corporate Officer/Principal | - |
Opleiding van Haibo Wang
| The Johns Hopkins University | Graduate Degree |
| Tsinghua University | Undergraduate Degree |
| Duke University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| HARPOON THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Hummingbird Bioscience Pte Ltd.
Hummingbird Bioscience Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Hummingbird Bioscience Pte Ltd. operates as a biotechnology company. It engages in the research and development of novel cancer immuno-therapeutics. The firm develops antibodies against a number of oncology and immuno-oncology targets. The company was founded by Jerome Boyd-Kirkup, Piers Ingram, and Lan Zhang in 2015 and is headquartered in Singapore. | Commercial Services |
